Camlin Fine Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)
Camlin Fine Sciences Ltd · Financial Result · 03 Nov 2026, 9:11 pm
Camlin Fine Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 4,915 (+9.2% YoY | -5.5% QoQ) ■ EBITDA: 22.3 (-93.7% YoY | -75.9% QoQ) ■ EBITDA Margin (%): 0.5 (-746 bps YoY | -133 bps QoQ) ■ PAT: -279 (-93.6% YoY | +12.1% QoQ) ■ EPS (INR): -1.45 (-88.3% YoY | +12.1% QoQ) Camlin Fine Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) Segmental Performance Specialty Ingredients ■ Revenue: 4,079 (+26.2% YoY | +1.6% QoQ) ■ EBIT: 328 (-8.6% YoY | +28.8% QoQ) ■ EBIT Margin (%): 8.0 (-307 bps YoY | +169 bps QoQ) Aroma ■ Revenue: 472 (-40.9% YoY | -39.1% QoQ) ■ EBIT: -109 (Profit to Loss YoY | -222.1% QoQ) ■ EBIT Margin (%): -23.1 (Profit to Loss YoY | -1873 bps QoQ) Performance Chemicals & Others ■ Revenue: 1,857 (+18.1% YoY | +6.2% QoQ) ■ EBIT: -197 (-119.5% YoY | -342.9% QoQ) ■ EBIT Margin (%): -10.6 (-490 bps YoY | -805 bps QoQ)
Original exchange filing (PDF)
More announcements from Camlin Fine Sciences Ltd
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November .... · 13 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 13, 2026 for Ashish Subhash Dandekar · 13 Nov 2026
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November .... · 09 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 09, 2026 for Ashish Subhash Dandekar · 09 Nov 2026
- Earnings call Transcript - Q2 & H1FY27 · 06 Nov 2026
- Audio Recording of the Investor Call - Q2 & H1FY27 · 04 Nov 2026
- Investor Presentation - Q2 & H1FY27 · 03 Nov 2026
- Camlin Fine Sciences Limited has informed the Exchange regarding Outcome of Board Meeting for raising of fund by way of issue of equity shares held on November 03, 2026. · 03 Nov 2026
